We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTX
5076
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$168K ﹤0.01%
16,389
-4,717
-22% -$51.6K
ADMS
5077
DELISTED
Adamas Pharmaceuticals
ADMS
$168K ﹤0.01%
38,745
-15,453
-29% -$66.1K
ETACU
5078
DELISTED
E.Merge Technology Acquisition Corp. Unit
ETACU
$167K ﹤0.01%
15,700
HZAC.WS
5079
DELISTED
Horizon Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary sh
HZAC.WS
$167K ﹤0.01%
+115,000
New +$143K
SAMG icon
5080
Silvercrest Asset Management
SAMG
$79.3M
$166K ﹤0.01%
11,968
+13
+0.1% +$166
FUSN
5081
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$166K ﹤0.01%
+14,157
New +$178K
ETHZW
5082
DELISTED
ETHZilla Corp Warrant
ETHZW
$165K ﹤0.01%
+500,000
New +$116K
INFI
5083
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$165K ﹤0.01%
77,940
+23,518
+43% +$38.8K
AQMS icon
5084
Aqua Metals
AQMS
$9.53M
$164K ﹤0.01%
272
-1
-0.4% -$248
ASX icon
5085
ASE Group
ASX
$81.9B
$164K ﹤0.01%
28,023
-131,779
-82% -$658K
MFIN icon
5086
Medallion Financial
MFIN
$250M
$164K ﹤0.01%
33,388
-1,353
-4% -$5.34K
SMMT icon
5087
Summit Therapeutics
SMMT
$10.8B
$164K ﹤0.01%
+34,809
New +$147K
VTGN icon
5088
VistaGen Therapeutics
VTGN
$12.6M
$163K ﹤0.01%
2,806
-1,906
-40% -$48.6K
WRAP icon
5089
Wrap Technologies
WRAP
$109M
$163K ﹤0.01%
33,727
+16,892
+100% +$98.1K
PSEC icon
5090
Prospect Capital
PSEC
$1.11B
$162K ﹤0.01%
30,024
-11,200
-27% -$59K
TH icon
5091
Target Hospitality
TH
$1.59B
$162K ﹤0.01%
102,438
-5,004
-5% -$7.13K
TZOO icon
5092
Travelzoo
TZOO
$73.4M
$162K ﹤0.01%
17,182
+265
+2% +$2.28K
ROCH
5093
DELISTED
Roth CH Acquisition I Co. Common Stock
ROCH
$162K ﹤0.01%
10,025
-1,675
-14% -$19.7K
NVGS icon
5094
Navigator Holdings
NVGS
$1.29B
$160K ﹤0.01%
14,626
+710
+5% +$6.02K
APTX
5095
DELISTED
Aptinyx Inc. Common Stock
APTX
$160K ﹤0.01%
46,406
+2,006
+5% +$6.99K
TPCO
5096
DELISTED
Tribune Publishing Company Common Stock
TPCO
$160K ﹤0.01%
+11,651
New +$144K
NESR
5097
National Energy Services Reunited Corp
NESR
$2.91B
$159K ﹤0.01%
16,028
-5,680
-26% -$47.1K
USX
5098
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$159K ﹤0.01%
23,186
-87,542
-79% -$684K
KIO
5099
KKR Income Opportunities Fund
KIO
$452M
$157K ﹤0.01%
+10,888
New +$152K
PLYM
5100
DELISTED
Plymouth Industrial REIT
PLYM
$157K ﹤0.01%
10,464
-44,199
-81% -$591K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.